BIO-B
Bio-Rad Laboratories Inc
365.10$
+0.0%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.5% | 24.8% | 24.3% | 31.5% | 28.8% | 32.4% | 31.9% | 27.5% | 29.3% | 27.5% | 30.1% | 29.5% | |
| 3.8% | 3.3% | 3.4% | 4.2% | 3.9% | 5.2% | 5.5% | 3.6% | 4.1% | 5.0% | 5.2% | 5.0% | |
| 14.8% | 13.1% | 13.1% | 16.7% | 15.3% | 17.8% | 17.4% | 13.5% | 14.7% | 14.6% | 16.0% | 15.8% | |
| 3.8% | 4.0% | 3.5% | 4.6% | 4.4% | 4.8% | 4.5% | 4.6% | 4.9% | 4.5% | 4.4% | 4.3% | |
| 6.5% | 6.3% | 6.2% | 8.3% | 7.6% | 8.1% | 8.3% | 7.8% | 8.1% | 7.0% | 7.9% | 7.6% | |
| 6.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 3.4% | 3.4% | 3.3% | 4.3% | 3.9% | 4.4% | 4.4% | 5.7% | 6.0% | 5.5% | 5.9% | 5.6% | |
| 2.6% | 2.6% | 2.5% | 3.2% | 2.9% | 3.1% | 3.1% | 3.9% | 4.0% | 1.6% | 1.7% | 1.6% | |
| 29.3% | 28.9% | 28.2% | 30.0% | 29.4% | 29.8% | 29.9% | 30.2% | 30.5% | 29.5% | 30.0% | 30.0% | |
| 4.7% | 4.3% | 3.7% | 5.0% | 4.7% | 5.0% | 5.3% | 5.4% | 5.4% | 4.9% | 9.4% | 9.4% | |
| 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.5% | 0.4% | 0.4% | 0.4% | 0.4% | 4.5% | 3.9% | |
| 0.9% | 1.2% | 0.8% | 1.3% | 1.2% | 1.3% | 1.4% | 1.4% | 1.3% | 1.2% | 1.4% | 1.4% | |
| 10.1% | 9.7% | 9.4% | 12.3% | 11.3% | 12.8% | 12.6% | 11.8% | 12.4% | 11.4% | 8.2% | 7.8% | |
| 70.7% | 71.1% | 71.8% | 70.0% | 70.6% | 70.2% | 70.1% | 69.8% | 69.5% | 70.5% | 70.0% | 70.0% | |
| 74.9% | 75.3% | 76.5% | 77.2% | 76.7% | 79.2% | 78.5% | 76.3% | 76.9% | 77.3% | 78.1% | 78.2% | |
| 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.